Spain Cancer Diagnostics Market Segmentation Analysis, 2019-2023: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

The new report is based on a study of the major business opportunities emerging in the Spanish cancer diagnostics market during the next five years. The report examines trends in the Spanish market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Spanish cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Spanish Market Overview

- Five-year test volume and sales projections.
- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.
- Estimated universe of laboratories performing cancer diagnostic testing.
- Cancer statistics, etiology and recent developments in Spain.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

- Oncogenes
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Hormones
- Immunohistochemical Stains
- Lymphokines

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product suppliers by individual test.

- Five-year test volume and sales forecasts for major tumor markers by market segment, including:

º  Hospitals

º  Commercial/Private Laboratories

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

- Assessment of latest technologies and their potential applications for cancer diagnostic testing.
- Review of competing/complementing technologies.
- Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

Contains 565 pages and 85 tables

I. Introduction
II. Worldwide Market Overview
A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth
III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Market and Technology Overview
A. Major Current and Emerging Cancer Diagnostic Tests
1. Biochemical Tumor Markers

2. Oncogenes

3. Polypeptide Growth Factors

4. Ectopic Hormones
5. Colony Stimulating Factors
6. Lymphokines
7. Immunohistochemical Stains
8. Emerging Tumor Markers

B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies

D. Personal Testing
VIII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
IX. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group

- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila

X. Appendix: Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications

List Of Tables



Cancer Diagnostic Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests

Major Companies Developing or Marketing
HCG Tests

Major Companies Developing or Marketing
Insulin Tests

Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis

Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: Spain, Total
Cancer Diagnostic Testing Volume and Sales
Forecasts by Market Segment
Spain, Estimated Cancer Death Rates
Spain, Laboratories Performing Cancer
Diagnostic Tests by Market Segment
Spain, Hospital Laboratories Performing
Cancer Diagnostic Tests by Bed Size
Spain, Commercial/Private Laboratories
Performing Cancer Diagnostics Tests
By Annual Test Volume
Spain, Total Cancer Diagnostic Test Volume
Forecasts by Market Segment
Spain, All Market Segment Major Cancer
Diagnostic Test Volume Forecasts
Spain, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecasts by Test
Spain, Commercial/Private Laboratories
Major Cancer Diagnostic Test Volume Forecasts
Spain, Total Cancer Diagnostic Sales
Forecasts by Market Segment

Spain, All Market Segments Major Cancer
Diagnostic Sales Forecasts by Test
Spain, Hospital Laboratories Major Cancer
Diagnostic Sales Forecasts by Test
Spain, Commercial/Private Laboratories Major
Cancer Diagnostic Sales Forecasts by Test
Spain, AFP Test Volume and Diagnostics Sales
Forecasts by Market Segment
Spain, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecasts by Market Segment
Spain, CA 15-3 Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, CA 19-9 Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, CA-125 Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, Calcitonin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, CEA Test Volume and Diagnostics Sales
Forecasts by Market Segment
Spain, Colon-Specific Antigen Test Volume and
Diagnostics Sales Forecasts by Market Segment
Spain, Estrogen Receptor Test Volume and
Diagnostics Sales Forecasts by Market Segment
Spain, Ferritin Test Volume and Diagnostics
Sales Forecasts by Market Segment

Spain, Gastrin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, HCG Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, Insulin Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, Lymphocyte Subtyping
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, NSE Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, Occult Blood Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Spain, Oncogenes Test Volume and
Diagnostics Sales Forecasts by Market
Segment

Spain, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, PAP Smear Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Spain, Parathyroid Hormone Test Volume
And Diagnostics Sales Forecasts by Market
Segment
Spain, Progesterone Receptor
Test Volume and Diagnostics Sales Forecasts
By Market Segment

Spain, PAP Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, PSA Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, S-100 Protein Test Volume
And Diagnostics Sales Forecasts by Market
Segment
Spain, Serotonin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Spain, Sialic Acid Test Volume and
Diagnostics Sales Forecasts by Market
Segment
Spain, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales Forecasts
by Market Segment
Spain, TDT Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, Thymidine Kinase
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, Thyroglobulin
Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, TPA Test Volume and Diagnostics
Sales Forecasts by Market Segment
Spain, Total Cancer Diagnostics Sales
By Major Suppliers

Spain, AFP Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics
Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics
Sales by Major Supplier
Spain, CEA Testing Market Diagnostics
Sales by Major Supplier
Spain, PSA Testing Market Diagnostics
Sales by Major Supplier

Spain Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities

LeadingMarketResearch.coms new study is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Spanish hematology and flow cytometry markets during the next

USD 4500 View Report

Europe Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests:France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

This comprehensive five-country report contains 450 pages, 160 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European hematology

USD 17500 View Report

Asia Pacific Kidney Cancer Diagnostics and Therapeutics Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Kidney Cancer Diagnostics and Therapeutics market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX

USD 3000 View Report

Cancer Diagnostics Market on the Verge of Explosion--Country Shares and Market Segment Forecasts for over 40 Tests--Technological Breakthroughs, Emerging Tests, Competitive Intelligence

This’s new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe

USD 18500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available